# Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

> **NCT02434614** · PHASE3 · UNKNOWN · sponsor: **Wei Jiang** · enrollment: 440 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Docetaxel,Cisplatin,Fluorouracil
- **RADIATION:** Intensity-modulated radiation therapy (IMRT)
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT02434614
- **Lead sponsor:** Wei Jiang
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2021-05
- **Final completion:** 2021-12
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2018-05-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02434614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02434614, "Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02434614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*